Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, today announced the launch of Ncyte® ...

Researchers at the Institute of Environmental Medicine, Karolinska Institutet have taken an important step toward ...

A study led by Turkish researcher Pinar Ayata unveiled a critical mechanism involving microglia—specialized immune cells in the brain—that could open new avenues for treating Alzheimer's ...

Researchers at the Institute of Environmental Medicine, Karolinska Institutet have taken an important step toward ...

Researchers investigate the sex-dependent microglial response to a colony-stimulating factor 1 receptor (CSF1R) inhibitor.

and the expression of microglial markers including IBA1, TREM2, and TMEM119. These features make Ncyte® Microglia highly suitable for studying microglial behavior in disease-relevant contexts ...

and the expression of microglial markers including IBA1, TREM2, and TMEM119. These features make Ncyte® Microglia highly suitable for studying microglial behavior in disease-relevant contexts ...